Celsius (NASDAQ:CELH) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.

Stock analysts at JPMorgan Chase & Co. initiated coverage on shares of Celsius (NASDAQ:CELH) in a research report issued on Thursday, Marketbeat reports. The firm set an “overweight” rating and a $37.00 price target on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 16.39% from the company’s previous close.

Other equities analysts have also issued reports about the stock. LADENBURG THALM/SH SH reduced their target price on shares of Celsius from $72.00 to $68.00 and set a “neutral” rating on the stock in a research report on Monday, October 21st. Piper Sandler decreased their target price on Celsius from $50.00 to $47.00 and set an “overweight” rating for the company in a research report on Tuesday, September 24th. Stifel Nicolaus lowered their target price on Celsius from $51.00 to $45.00 and set a “buy” rating for the company in a report on Thursday, November 7th. UBS Group cut their price target on Celsius from $50.00 to $45.00 and set a “buy” rating on the stock in a research note on Thursday, November 7th. Finally, Needham & Company LLC started coverage on shares of Celsius in a research note on Friday, December 6th. They issued a “buy” rating and a $38.00 price objective for the company. One research analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, Celsius presently has a consensus rating of “Moderate Buy” and an average target price of $51.28.

Celsius Price Performance

CELH stock opened at $31.79 on Thursday. Celsius has a 12 month low of $25.23 and a 12 month high of $99.62. The firm’s 50-day moving average is $30.02 and its 200 day moving average is $42.17. The company has a market capitalization of $7.47 billion, a PE ratio of 44.15, a P/E/G ratio of 3.44 and a beta of 1.76.

Institutional Trading of Celsius

Several large investors have recently added to or reduced their stakes in the company. Livforsakringsbolaget Skandia Omsesidigt acquired a new stake in shares of Celsius during the third quarter worth about $34,000. Signaturefd LLC lifted its stake in Celsius by 48.3% during the 3rd quarter. Signaturefd LLC now owns 1,160 shares of the company’s stock valued at $36,000 after acquiring an additional 378 shares during the period. Benjamin F. Edwards & Company Inc. boosted its holdings in shares of Celsius by 353.1% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 648 shares of the company’s stock valued at $37,000 after acquiring an additional 505 shares during the last quarter. Newbridge Financial Services Group Inc. boosted its holdings in shares of Celsius by 3,150.0% in the 2nd quarter. Newbridge Financial Services Group Inc. now owns 650 shares of the company’s stock valued at $37,000 after acquiring an additional 630 shares during the last quarter. Finally, Activest Wealth Management acquired a new stake in shares of Celsius in the third quarter worth $39,000. Hedge funds and other institutional investors own 60.95% of the company’s stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.